This symposium recording was provided by Incyte Biosciences International Sàrl following a request from EMJ, in the context of an unrestricted educational grant.
This Industry Satellite Symposium from ESMO 2025 brings together four leading experts, Sheela Rao, Christelle de la Fouchardière , Gunnar Folprecht , Dominik Modest, to explore cutting-edge developments in squamous cell anal cancer (SCAC) and colorectal cancer (CRC).
The program features comprehensive coverage of SCAC from epidemiology, diagnosis, and prevention strategies through to multidisciplinary approaches for early-stage disease and current treatment options for advanced cases. The symposium also examines the evolving treatment landscape in advanced anal cancer and explores promising therapeutic targets in CRC, including KRAS inhibition and TGF-β pathways.
Through informative presentations, case studies, and interactive panel discussion, this on-demand symposium offers valuable insights into the latest advances in managing these important malignancies.
Speakers:
Sheela Rao1
Christelle de la Fouchardièr2
Gunnar Folprecht3
Dominik Modest44
1. Gastrointestinal Unit, Royal Marsden Hospital, London, UK
2. Paoli-Calmettes Institute, Marseille, France
3. University Hospital Carl Gustav Carus, Dresden, Germany
4. Charité Universitätsmedizin, Berlin, Germany
